本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Biohaven Pharmaceutical Holding Co Ltd.

20.55
-3.1300-13.22%
盤後20.54-0.0100-0.05%18:51 EDT
成交量:268.19萬
成交額:5,631.69萬
市值:20.97億
市盈率:-2.22
高:22.24
開:21.95
低:20.41
收:23.68
資料載入中...
2024/02/29

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/08

重要事件披露

Form 8-K - Current report
2023/12/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/15

重要事件披露

Form 8-K - Current report
2023/11/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/19

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/10/06

重要事件披露

Form 8-K - Current report
2023/10/03

重要事件披露

Form 8-K - Current report
2023/09/27

重要事件披露

Form 8-K - Current report
2023/07/31

重要事件披露

Form 8-K - Current report
2023/07/31

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/29

重要事件披露

Form 8-K - Current report
2023/05/31

重要事件披露

Form 8-K - Current report
2023/05/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/12

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/05/12

重要事件披露

Form 8-K - Current report
2022/10/04

交易所摘牌聲明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2022/10/03

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments